wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q54313994-359427A9-B67C-485D-97DD-40E87F068B1F
Q54313994-359427A9-B67C-485D-97DD-40E87F068B1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54313994-359427A9-B67C-485D-97DD-40E87F068B1F
Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas.
P2860
Q54313994-359427A9-B67C-485D-97DD-40E87F068B1F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q54313994-359427A9-B67C-485D-97DD-40E87F068B1F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5bacdccb18e6789fe62d8777bddcd29585e9c0a7
P2860
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07).